Can't kick that oncogene habit.

Abstract excerpt

One of the most exciting developments in recent cancer treatment has been the move away from crude cytotoxic agents toward drugs that inhibit specific targets in specific cellular pathways. One assumption of this strategy is that maintenance of human cancers is dependent upon a limited cadre of therapeutically tractable oncogenic lesions. In this issue of Cancer Cell, an intriguing paper from Sharma et al....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Apoptosis
• Share to Mutation
• Share to Neoplasms